Pancreatic Cancer Research

ResearcherWannan Medical CollegeActive in the last 2 years

Lei Jin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7187-9671; OpenAlex author ID A5072527322, A5100607106. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 6

  1. tRF-Pro-CGG Suppresses Cell Proliferation and Promotes Apoptosis in Pancreatic Cancer. Co-author DOI 10.1007/s10620-025-08943-x↗
  2. SMYD2 Imparts Gemcitabine Resistance to Pancreatic Adenocarcinoma Cells by Upregulating EVI2A. Co-author DOI 10.1007/s12033-023-00908-7↗
  3. The biological behavior of tRNA-derived fragment tRF-Leu-AAG in pancreatic cancer cells. Co-author DOI 10.1080/21655979.2022.2064206↗
  4. Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma. First author DOI 10.1002/jcla.23742↗
  5. Insight into the effects of microRNA-23a-3p on pancreatic cancer and its underlying molecular mechanism. First author DOI 10.3892/ol.2019.11117↗
  6. Expression profile of tRNA-derived fragments in pancreatic cancer. Co-author DOI 10.3892/ol.2019.10601↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunfu Zhu · 5 shared papers, 2019–2025 · strength 0.83
  2. Xihu Qin · 3 shared papers, 2019–2025 · strength 0.51
  3. Jiadeng Chao · 2 shared papers, 2020–2025 · strength 0.34
  4. Shizhen Sui · 2 shared papers, 2021–2022 · strength 0.33
  5. Daohai Qian · 1 shared paper, 2024 · strength 0.26
  6. Zhaoying Wu · 1 shared paper, 2024 · strength 0.26
  7. Cailin Xue · 1 shared paper, 2025 · strength 0.25
  8. Jikuan Zhu · 1 shared paper, 2025 · strength 0.25
  9. ­Jun Li­ · 1 shared paper, 2025 · strength 0.25
  10. Xiaohan Cui · 1 shared paper, 2022 · strength 0.20
  11. Jun Li · 1 shared paper, 2021 · strength 0.12
  12. Jun Li · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.